Effects of Sodium Glucose Co-Transporter 2 Inhibitor Canagliflozin in Patients with Type 2 Diabetes and Chronic Heart Failure (CANDLE): An Open-Label, Randomized Controlled Trial
2013 ◽
Vol 4
(8)
◽
pp. 245-249
◽
2017 ◽
Vol 19
(5)
◽
pp. 654-663
◽
Keyword(s):